TSO3 Inc (TOS):医療機器:M&Aディール及び事業提携情報

◆英語タイトル:TSO3 Inc (TOS) - Medical Equipment - Deals and Alliances Profile
◆商品コード:DATA904C7117
◆発行会社(調査会社):GlobalData
◆発行日:2018年10月
◆ページ数:30
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:カナダ
◆産業分野:医療機器
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD250 ⇒換算¥37,000見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD500 ⇒換算¥74,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD750 ⇒換算¥111,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
TSO3 Inc (TSO3) designs develops, manufactures, markets and licenses sterilization processes for heat-sensitive medical devices. The company’s area of focus is sterile processing, which provides a replacement solution to other low temperature sterilization processes used in hospitals. The company’s flagship product is Sterizone VP4 Sterilizer, a dual sterilant, low-temperature sterilization system, which utilizes vaporized hydrogen peroxide and ozone. The company’s product is based on its patented Sterizone sterilization platform. The company also offers services such as maintenance of sterilization equipment and compatibility testing of medical devices. The product finds use in hospitals and clinical settings with high patient turnover. TSO3 is headquartered in Quebec, Canada.

TSO3 Inc (TOS) – Medical Equipment – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Medical eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 4
List of Figures 4
TSO3 Inc, Medical Equipment, Deals By Year, 2012 to YTD 2018 5
TSO3 Inc, Medical Equipment Deals By Type, 2012 to YTD 2018 6
TSO3 Inc, Medical Equipment, Deals By Region, 2012 to YTD 2018 7
TSO3 Inc, Medical Equipment, Deals By Market, 2012 to YTD 2018 8
TSO3 Inc, Medical Equipment, Deals Summary, 2012 to YTD 2018 9
TSO3 Inc, Medical Equipment, Deal Details 10
Partnerships 10
Getinge Infection Control Enters into Distribution Agreement with TSO3 10
Equity Offering 11
Tso3 Raises USD9 Million in Public Offering of Units 11
Tso3 Completes Public Offering Of Shares For US$6.9 Million 12
TSO3 Completes Private Placement Of Units For US$9 Million 13
TSO3 Inc – Key Competitors 14
TSO3 Inc – Key Employees 15
TSO3 Inc – Locations And Subsidiaries 16
Head Office 16
Other Locations & Subsidiaries 16
Recent Developments 17
Financial Announcements 17
May 08, 2018: TSO3 Reports First Quarter 2018 Results 17
Nov 06, 2017: TSO3 Reports Record Third Quarter 2017 Results 18
Aug 01, 2017: TSO3 Reports Record Second Quarter 2017 Results 19
May 10, 2017: TSO3 Reports Record First Quarter 2017 Results 20
Mar 21, 2017: TSO3 Reports Record Fourth Quarter and Full Year 2016 Results 22
Corporate Communications 24
Aug 29, 2018: TSO3 names Martin J. Madden as board director 24
Apr 02, 2018: TSO3 Appoints Dr. Douglas Dieter to its Board of Directors 25
Sep 25, 2017: TSO3 Appoints Dr. Bradley J. Catalone as Chief Science Officer 26
Feb 16, 2017: TSO3 Appoints Dr. Linda Rosenstock and Mr. Jeffrey Pompeo to its Board of Directors 27
Feb 02, 2017: TSO3 Appoints Mark Pasmore as Vice President of Research and Development 28
Other Significant Developments 29
Jan 25, 2018: TSO3 Provides an Operational Update 29
Appendix 30
Methodology 30
About GlobalData 30
Contact Us 30
Disclaimer 30

List of Tables
TSO3 Inc, Medical Equipment, Key Facts, 2017 2
TSO3 Inc, Medical Equipment, Deals Summary, 2012 to YTD 2018 2
TSO3 Inc, Medical Equipment, Deals By Year, 2012 to YTD 2018 5
TSO3 Inc, Medical Equipment Deals By Type, 2012 to YTD 2018 6
TSO3 Inc, Medical Equipment, Deals By Region, 2012 to YTD 2018 7
TSO3 Inc, Deals By Market, 2012 to YTD 2018 8
TSO3 Inc, Medical Equipment, Deals Summary, 2012 to YTD 2018 9
Getinge Infection Control Enters into Distribution Agreement with TSO3 10
Tso3 Raises USD9 Million in Public Offering of Units 11
Tso3 Completes Public Offering Of Shares For US$6.9 Million 12
TSO3 Completes Private Placement Of Units For US$9 Million 13
TSO3 Inc, Key Competitors 14
TSO3 Inc, Key Employees 15
TSO3 Inc, Subsidiaries 16

List of Figures
TSO3 Inc, Medical Equipment, Deals by Type, 2012 to YTD 2018 2
TSO3 Inc, Medical Equipment, Deals By Year, 2012 to YTD 2018 2
TSO3 Inc, Medical Equipment, Deals By Region, 2012 to YTD 2018 2
TSO3 Inc, Medical Equipment, Deals By Market, 2012 to YTD 2018 2
TSO3 Inc, Medical Equipment, Deals By Year, 2012 to YTD 2018 5
TSO3 Inc, Medical Equipment, Deals by Type, 2012 to YTD 2018 6
TSO3 Inc, Medical Equipment, Deals By Region, 2012 to YTD 2018 7
TSO3 Inc, Medical Equipment, Deals by Market, 2012 to YTD 2018 8

★海外企業調査レポート[TSO3 Inc (TOS):医療機器:M&Aディール及び事業提携情報]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Kohinoor Energy Limited:発電所・企業SWOT分析
    Kohinoor Energy Limited - Power Plants and SWOT Analysis, 2017 Update Summary The report contains a detailed description of the power generation company’s business operations, history, corporate strategy, and business structure. This report contains a detailed SWOT analysis, information on key emplo …
  • Little Caesar Enterprises Inc:企業の戦略・SWOT・財務情報
    Little Caesar Enterprises Inc - Strategy, SWOT and Corporate Finance Report Summary Little Caesar Enterprises Inc - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and …
  • Wageningen University-製薬・医療分野:企業M&A・提携分析
    Summary Wageningen University (WU), a subsidiary of Wageningen University and Research Centre, is an education and research institution. The university offers bachelors’, masters’ and PhD programs. It specializes in healthy food and living environment domain. WU offers various courses in bachelor of …
  • ERHC Energy Inc:石油・ガス:M&Aディール及び事業提携情報
    Summary ERHC Energy Inc (ERHC Energy) is an exploration and production company that explores oil and gas assets. The company possesses deep water oil and gas exploration and production interests in the Gulf of Guinea and onshore interests in Republic of Chad and Republic of Kenya. It holds interests …
  • Celsion Corp (CLSN)-製薬・医療分野:企業M&A・提携分析
    Summary Celsion Corp (Celsion) is an oncology company that focuses on developing a portfolio of new cancer treatments, including directed chemotherapies, RNA based therapies and DNA-mediated immunotherapy. The company’s three platform technologies including Lysolipid Thermally Sensitive Liposomes (L …
  • NCC Ltd (NCC):企業の財務・戦略的SWOT分析
    NCC Ltd (NCC) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the pot …
  • Arkema SA:企業のM&A・事業提携・投資動向
    Arkema SA - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's Arkema SA Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acquisitions (M&A), divestments, capita …
  • Valener Inc:企業の戦略的SWOT分析
    Valener Inc - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and services. …
  • Robert Bosch GmbH:企業の戦略・SWOT・財務分析
    Robert Bosch GmbH - Strategy, SWOT and Corporate Finance Report Summary Robert Bosch GmbH - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and c …
  • Neurolixis Inc:製薬・医療:M&Aディール及び事業提携情報
    Summary Neurolixis Inc (Neurolixis) is an early-stage biopharmaceutical company that discovers and develops novel drugs for the treatment of human central nervous system disorders. The company’s pipeline product portfolio includes NLX-112, a drug candidate intended for the treatment of L-DOPA-induce …
  • Bashneft (BANE):石油・ガス:M&Aディール及び事業提携情報
    Summary Bashneft is a vertically integrated oil and gas company. It operates in the oil and gas production, refining, petrochemical production, marketing and distribution of oil and petroleum products. It sales crude oil, petroleum products and petrochemical products to the domestic market. The comp …
  • CSS Industries, Inc. (CSS):企業の財務・戦略的SWOT分析
    CSS Industries, Inc. (CSS) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesse …
  • PetroRio SA (PRIO3):企業の財務・戦略的SWOT分析
    Summary PetroRio SA (PetroRio), formerly HRT Participacoes em Petroleo SA, a subsidiary of HRT Oil & Gas Ltd, is oil and gas company. It offers investment and recovering of oil production assets. The company provides development of solid growth platforms aiming to generate value to its shareholders …
  • Deutsche Biotech Innovativ AG (VUA)-製薬・医療分野:企業M&A・提携分析
    Summary Deutsche Biotech Innovativ AG (DBI), formerly Venetus Beteiligungen AG is a biotechnology company that develops drug candidates on indications sepsis and cancer. The company’s products comprise Adrecizumab, DB1RA and AB2302. It diagnostic based drug development approach and offers identifica …
  • Poudre Valley Rural Electric Association, Inc.:発電所・企業SWOT分析
    Poudre Valley Rural Electric Association, Inc. - Power Plants and SWOT Analysis, 2017 Update Summary The report contains a detailed description of the power generation company’s business operations, history, corporate strategy, and business structure. This report contains a detailed SWOT analysis, i …
  • Bank of Taiwan:企業の戦略・SWOT・財務分析
    Bank of Taiwan - Strategy, SWOT and Corporate Finance Report Summary Bank of Taiwan - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corpora …
  • Chicago Bridge & Iron Company NV (CBI)-エネルギー分野:企業M&A・提携分析
    Summary Chicago Bridge & Iron Company N.V. (CB&I) is a provider of technology and infrastructure solutions. Its services include conceptual design, technology, engineering, procurement, modularization, construction, fabrication, commissioning, maintenance, program management and environmental servic …
  • LHC Group, Inc.:企業のM&A・事業提携・投資動向
    LHC Group, Inc. - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's LHC Group, Inc. Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acquisitions (M&A), divestm …
  • First Takaful Insurance Company:企業の戦略・SWOT・財務情報
    First Takaful Insurance Company - Strategy, SWOT and Corporate Finance Report Summary First Takaful Insurance Company - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product …
  • WD-40 Company (WDFC):企業の財務・戦略的SWOT分析
    Summary WD-40 Company (WD-40) is a lubricant distributor. The company develops and markets maintenance products, and homecare and cleaning products. Its products are used in rust and corrosion resistive, penetrates stuck parts, and moisture barriers. WD-40 also provides surface cleaners and automati …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆